Want to track NOV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NOV earnings report is expected in 70 days (5 May 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
 | | 5.18 | - |
| | | - | - |
| | | 5.78 | - |
| | | 4.95 | - |
| | | 6.05 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
NOV Earnings Reports FAQ
What is the earnings per share (EPS) for NOV?
EPS data for NOV is currently not available, as Novo Nordisk A/S has not reported recent earnings.
What is the company's earnings growth rate?
Novo Nordisk A/S has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-05-05, based on the NOV's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Novo Nordisk A/S are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for NOV at this time, as Novo Nordisk A/S has no recent EPS data to calculate it.
